Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miriam Kuppermann is active.

Publication


Featured researches published by Miriam Kuppermann.


Health Psychology | 2000

Objective and Subjective Assessments of SocioEconomic Status and their Relationship to Self-Rated Health in an Ethnically Diverse Sample of Pregnant Women

Joan M. Ostrove; Nancy E. Adler; Miriam Kuppermann; A. Eugene Washington

A new measure of subjective socioeconomic status (SES) was examined in relation to self-rated physical health in pregnant women. Except among African Americans, subjective SES was significantly related to education, household income, and occupation. Subjective SES was significantly related to self-rated health among all groups. In multiple regression analyses, subjective SES was a significant predictor of self-rated health after the effects of objective indicators were accounted for among White and Chinese American women; among African American women and Latinas, household income was the only significant predictor of self-rated health. After accounting for the effects of subjective SES on health, objective indicators made no additional contribution to explaining health among White and Chinese American women; household income continued to predict health after accounting for subjective SES among Latinas and African American women.


Journal of General Internal Medicine | 1995

Sleep problems and their correlates in a working population

Miriam Kuppermann; Deborah P. Lubeck; Peter D. Mazonson; Donald L. Patrick; Anita L. Stewart; Don P. Buesching; Sheila K. Filer

AbstractOBJECTIVE: To measure the prevalence of sleep problems in a working population and examine their association with health problems, health-related quality-of-life measures, work-related problems, and medical expenditures. Also, to explore the usefulness of a sleep-problems screen for mental health conditions and underlying sleep disorders. DESIGN: Cross-sectional survey administered via voice mail and telephone interview. SETTING: A San Francisco Bay Area telecommunications firm. PARTICIPANTS: Volunteer sample of 588 employees who worked for a minimum of six months at the company and were enrolled in its fee-for-service health plan. MEASUREMENTS AND MAIN RESULTS: Thirty percent of respondents reported currently experiencing sleep problems and were found to have worse functioning and well-being (general health, cognitive functioning, energy), more work-related problems (decreased job performance and lower satisfaction, increased absenteeism), and a greater likelihood of comorbid physical and mental health conditions than were the respondents who did not have sleep problems. They also demonstrated a trend toward higher medical expenditures. CONCLUSIONS: Self-perceived sleep problems were common among the respondents and were associated with poorer health and health-related quality of life. A single question about sleep problems may serve as an effective screen for identifying primary care patients with mental health problems, as well as underlying sleep disorders.


Annals of Internal Medicine | 2011

Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer: A Cost-Effectiveness Analysis

Uri Ladabaum; Grace Wang; Jonathan P. Terdiman; Amie Blanco; Miriam Kuppermann; C. Richard Boland; James M. Ford; Elena B. Elkin; Kathryn A. Phillips

BACKGROUND Testing has been advocated for all persons with newly diagnosed colorectal cancer to identify families with the Lynch syndrome, an autosomal dominant cancer-predisposition syndrome that is a paradigm for personalized medicine. OBJECTIVE To estimate the effectiveness and cost-effectiveness of strategies to identify the Lynch syndrome, with attention to sex, age at screening, and differential effects for probands and relatives. DESIGN Markov model that incorporated risk for colorectal, endometrial, and ovarian cancers. DATA SOURCES Published literature. TARGET POPULATION All persons with newly diagnosed colorectal cancer and their relatives. TIME HORIZON Lifetime. PERSPECTIVE Third-party payer. INTERVENTION Strategies based on clinical criteria, prediction algorithms, tumor testing, or up-front germline mutation testing, followed by tailored screening and risk-reducing surgery. OUTCOME MEASURES Life-years, cancer cases and deaths, costs, and incremental cost-effectiveness ratios. RESULTS OF BASE-CASE ANALYSIS The benefit of all strategies accrued primarily to relatives with a mutation associated with the Lynch syndrome, particularly women, whose life expectancy could increase by approximately 4 years with hysterectomy and salpingo-oophorectomy and adherence to colorectal cancer screening recommendations. At current rates of germline testing, screening, and prophylactic surgery, the strategies reduced deaths from colorectal cancer by 7% to 42% and deaths from endometrial and ovarian cancer by 1% to 6%. Among tumor-testing strategies, immunohistochemistry followed by BRAF mutation testing was preferred, with an incremental cost-effectiveness ratio of


Circulation | 1990

An analysis of the cost effectiveness of the implantable defibrillator.

Miriam Kuppermann; B R Luce; B McGovern; P J Podrid; J T Bigger; Jeremy N. Ruskin

36,200 per life-year gained. RESULTS OF SENSITIVITY ANALYSIS The number of relatives tested per proband was a critical determinant of both effectiveness and cost-effectiveness, with testing of 3 to 4 relatives required for most strategies to meet a threshold of


Obstetrics & Gynecology | 2000

Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences.

Miriam Kuppermann; Robert F. Nease; Lee A. Learman; Elena Gates; Bruce Blumberg; A. Eugene Washington

50,000 per life-year gained. Immunohistochemistry followed by BRAF mutation testing was preferred in 59% of iterations in probabilistic sensitivity analysis at a threshold of


Obstetrics & Gynecology | 2006

Beyond race or ethnicity and socioeconomic status : Predictors of prenatal testing for down syndrome

Miriam Kuppermann; Lee A. Learman; Elena Gates; Steven E. Gregorich; Robert F. Nease; James Lewis; A. Eugene Washington

100,000 per life-year gained. Screening for the Lynch syndrome with immunohistochemistry followed by BRAF mutation testing only up to age 70 years cost


Obstetrics & Gynecology | 2005

Sexual functioning after total compared with supracervical hysterectomy: a randomized trial.

Miriam Kuppermann; Robert L. Summitt; R. Edward Varner; S. Gene McNeeley; Deborah Goodman-Gruen; Lee A. Learman; Christine C. Ireland; Eric Vittinghoff; Feng Lin; Holly E. Richter; Jonathan Showstack; Stephen B. Hulley; A. Eugene Washington

44,000 per incremental life-year gained compared with screening only up to age 60 years, and screening without an upper age limit cost


Obstetrics & Gynecology | 1996

Racial-ethnic differences in prenatal diagnostic test use and outcomes: Preferences, socioeconomics, or patient knowledge?*

Miriam Kuppermann; Elena Gates; Washington Ae

88,700 per incremental life-year gained compared with screening only up to age 70 years. LIMITATION Other types of cancer, uncertain family pedigrees, and genetic variants of unknown significance were not considered. CONCLUSION Widespread colorectal tumor testing to identify families with the Lynch syndrome could yield substantial benefits at acceptable costs, particularly for women with a mutation associated with the Lynch syndrome who begin regular screening and have risk-reducing surgery. The cost-effectiveness of such testing depends on the participation rate among relatives at risk for the Lynch syndrome. PRIMARY FUNDING SOURCE National Institutes of Health.


JAMA Internal Medicine | 2011

Oophorectomy vs Ovarian Conservation With Hysterectomy: Cardiovascular Disease, Hip Fracture, and Cancer in the Women's Health Initiative Observational Study

Vanessa L. Jacoby; Deborah Grady; Jean Wactawski-Wende; JoAnn E. Manson; Matthew A. Allison; Miriam Kuppermann; Gloria E. Sarto; John Robbins; Lawrence S. Phillips; Lisa W. Martin; Mary Jo O’Sullivan; Rebecca D. Jackson; Rebecca J. Rodabough; Marcia L. Stefanick

The automatic implantable defibrillator has been shown to decrease the mortality of patients who have survived cardiac arrest due to ventricular tachycardia or fibrillation and are at high risk for recurrence. We performed a cost-effectiveness analysis of this seemingly expensive new technology with data obtained from the 1984 Medicare data base, the medical literature, Medicare carriers, individual pharmacies and hospitals, and expert opinion. Analyzing combinations of principal and secondary discharge diagnoses across 18 diagnosis-related groups, we estimated the cost of hospitalization for a comparison group of patients. Hospitalization costs for the defibrillator group were obtained from reported empirical data. Rehospitalization rates and other health-care use estimates were solicited from an expert panel of physicians, and mortality rates for both groups were obtained from the literature. Using a decision-analytic model, we estimated that the net cost effectiveness of the defibrillator, when used in the high-risk patient, is approximately


American Journal of Obstetrics and Gynecology | 2010

Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.

Vanessa L. Jacoby; Victor Y. Fujimoto; Linda C. Giudice; Miriam Kuppermann; A. Eugene Washington

17,100 per life-year saved, with sensitivity analyses suggesting that the true value lies between

Collaboration


Dive into the Miriam Kuppermann's collaboration.

Top Co-Authors

Avatar

Sanae Nakagawa

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mary E. Norton

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elena Gates

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge